Venture Capital: Allozyne raises $30M for MS drug

Allozyne http://www.allozyne.com/ has raised a whopping $30 million in venture funding, money that the Seattle biotechnology upstart will use to develop a new multiple sclerosis treatment that could reduce the number of injections for patients from every other day to every other week.

By JOHN COOK
P-I REPORTER

Full Story: http://seattlepi.nwsource.com/venture/336921_vc26.html